Ken Buechler

TriVirum Board Member, 2020. Kenneth F. Buechler is the co-founder of Biosite Incorporated. He served as president and chief scientific officer and is a co-inventor of multiple proprietary technologies that have advanced rapid point-of-care medical diagnostics, which include the Triage Cardiac Panel, the Triage ProfilER Shortness of Breath Panel, the Triage BNP Test, the Triage Drugs of Abuse Panel and the Triage Meter Plus platform. Under his leadership, Biosite commercialized the first immunoassay to measure B-type natriuretic peptide (BNP), which in turn revolutionized how physicians diagnose and evaluate patients with congestive heart failure. In 2015, the University of California, San Diego, honored him for this specific advancement in cardiovascular care.

Prior to forming Biosite, Dr. Buechler was a senior research scientist at Hybritech Inc., where he was the project leader for cardiac biomarker assays. Additionally, he was responsible for the design and synthesis of reagents for use in the first rapid, visual pregnancy test, the ICON hCG. Dr. Buechler is currently the chairman of the board of Quidel Corporation, member of the board of directors for Rady Children’s Hospital Genomics Institute, and the previous chairman of the board of Sequenom Inc. He also was a director of Sotera Wireless Inc., Edico Genome Inc., and Astute Medical Inc. (BA, Chemistry, 1975; PhD, Biochemistry, 1981).